Harvard Bioscience reports fourth quarter and year-end 2015 results
Harvard Bioscience reported the GAAP net loss was $19.0 million, or $0.57 per diluted share, for the 2015 full year year versus net income of $2.4 million, or $0.07 per diluted share, in 2014. Revenues for the 2015 full year year were $108.7 million, and flat compared to revenues in 2014. April 29, 2016